AGHC Stock Overview
Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Aeon Global Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.05 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 33 Year Change | -99.91% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| AGHC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | 0.4% |
| 1Y | n/a | 2.3% | 22.9% |
Return vs Industry: Insufficient data to determine how AGHC performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how AGHC performed against the US Market.
Price Volatility
| AGHC volatility | |
|---|---|
| AGHC Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: AGHC has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AGHC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Sonny Roshan | www.aeonglobalhealth.com |
Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through Laboratory Testing Services and Web-Based Software segments. Its laboratory testing services include the testing of an individual’s blood, urine, or saliva for the presence of drugs or chemicals, as well as the patient’s DNA profile.
Aeon Global Health Corp. Fundamentals Summary
| AGHC fundamental statistics | |
|---|---|
| Market cap | US$991.00 |
| Earnings (TTM) | -US$8.32m |
| Revenue (TTM) | US$12.93m |
0.0x
P/S Ratio0.0x
P/E RatioIs AGHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AGHC income statement (TTM) | |
|---|---|
| Revenue | US$12.93m |
| Cost of Revenue | US$5.01m |
| Gross Profit | US$7.92m |
| Other Expenses | US$16.24m |
| Earnings | -US$8.32m |
Last Reported Earnings
Jun 30, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did AGHC perform over the long term?
See historical performance and comparison